← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2013Last known activity
May 27, 2025
Timeline
2000s
- Jun 1, 2001
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.— Founded
Drugs by trial phase (33 distinct, 68 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
- 23-valent pneumococcal polysaccharide vaccine
- bacille calmette-guerin
- pneumococcal 13-valent conjugate vaccine
- esat6-cfp10
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- Tuberculin, Purified Protein Derivative
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- rabies vaccine, human isolate
- s.flexneriza-s.sonnei bivalent conjugate vaccine
- 15-valent pneumococcal conjugate vaccine
- rabies vaccine
- tetravalent influenza virus lysis vaccine
- Monovalent group A meningococcal vaccine
- +3 more
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT06970756OfficialPhase 1May 27, 2025
- NCT06970756Lead sponsorPhase 1May 27, 2025
- NCT06824519Lead sponsorPhase 1/Phase 2May 8, 2025
- NCT06838195OfficialPhase 3Apr 15, 2025
- NCT06838195Lead sponsorPhase 3Apr 15, 2025
- NCT06747455Lead sponsorPhase 3Mar 20, 2025
- NCT06703203Lead sponsorPhase 1/Phase 2Aug 27, 2024
- NCT06524947Lead sponsorPhase 3Jul 27, 2024
- NCT06344065OfficialPhase 3Dec 21, 2023
- NCT06344065Lead sponsorPhase 3Dec 21, 2023
- NCT06100653Lead sponsorPhase 1Nov 22, 2023
- NCT06043388Lead sponsorPhase 1Sep 30, 2023
- NCT06025812Lead sponsorN/ASep 20, 2023
- NCT05899179Lead sponsorPhase 3Aug 3, 2023
- NCT06975774Lead sponsorPhase 1Jul 26, 2023
Details
- Founded
- Beijing, CN Jun 1, 2001
- Last known activity
- May 27, 2025